What Does a Fasting Insulin Test Measure?
A fasting insulin test measures total immunoreactive insulin in the blood, not free (unbound) insulin. Standard clinical insulin assays detect all insulin molecules that react with the antibodies used in the test, which includes both free insulin and insulin bound to antibodies (in insulin-treated patients), as well as some cross-reactivity with proinsulin 1.
Understanding the Test Components
What Standard Assays Measure
Modern immunometric insulin assays use monoclonal antibodies and are designed to measure total insulin with minimal cross-reactivity with proinsulin 2. However, these assays still cannot distinguish between:
- Free (biologically active) insulin - the unbound fraction that exerts metabolic effects
- Antibody-bound insulin - particularly relevant in insulin-treated diabetics who develop insulin antibodies 3, 4
Clinical Implications
The distinction between free and total insulin matters primarily in insulin-treated diabetics with circulating insulin antibodies, where total insulin levels may be markedly elevated while free insulin remains low 3. In these patients, only free insulin correlates with blood glucose control, not total insulin 4.
For non-insulin-treated individuals, this distinction is largely irrelevant since insulin antibodies are absent, and measured insulin represents predominantly free, biologically active hormone.
Important Clinical Caveats
Limited Clinical Utility
Measuring fasting insulin has no diagnostic value for most clinical purposes 5. The 2017 Endocrine Society guidelines explicitly state that fasting insulin measurements:
- Show considerable overlap between insulin-resistant and insulin-sensitive individuals
- Have no well-defined cutoff for abnormal values
- Lack standardized assays with poor reproducibility
- Are affected by race/ethnicity differences in insulin clearance
- Cannot distinguish between normal glucose tolerance and impaired glucose tolerance in obese youth 5
When Insulin Measurement IS Useful
Insulin and C-peptide measurements are clinically valuable primarily in:
- Hypoglycemia evaluation - diagnosing insulinoma or inappropriate insulin secretion during documented hypoglycemia (glucose <45-55 mg/dL) 6, 2
- Differentiating diabetes types - distinguishing type 1 from type 2 diabetes in ambiguous cases using C-peptide 1
- Investigating surreptitious insulin use - C-peptide will be suppressed with exogenous insulin administration 1
For routine diabetes screening, insulin resistance assessment, or obesity evaluation, fasting insulin measurement is not recommended and remains a research tool 5, 1.